InSights Hub

Miscellaneous


Showing 31 to 40 of 360 (Page 4)
Guidelines+ Trials Spotlight - Metastatic Squamous Cell Carcinoma of the Head & Neck (STELLAR-305)

Metastatic Squamous Cell Carcinoma of the Head and Neck (STELLAR-305) – Guidelines+ Trials Spotlight

Published on

One year ago, Exelixis commenced their phase 2/3 pivotal trial to assess the efficacy of zanzalintinib in combination with pembrolizumab compared to pembrolizumab alone in patients with previously untreated PD-L1-positive recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Zanzalintinib, an oral drug developed by Exelixis, targets and inhibits receptor tyrosine kinases […]

Read More
Focus
Clinical Trials
Specialties
Oncology

Baloxavir Marboxil (Xofluza/Genetech) – Guidelines+ Monographs

Published on

In recognition of National Influenza Vaccination Week (NIVW), our latest edition of the Guidelines+ Monographs Series will delve into the medication baloxavir marboxil, marketed under the brand name Xofluza®  by Genentech. Xofluza is an influenza virus polymerase acidic (PA) endonuclease inhibitor indicated for the treatment of acute uncomplicated influenza in patients 5 years of age […]

Read More
Focus
Medications
Specialties
Family Medicine • Infectious Diseases • Infectious Disease • Internal Medicine - General • Pediatrics • Adolescent Medicine • Pediatric Infectious Diseases • Public Health and General Preventive Medicine
Guidelines + Trials Rundown Thalassemia

Thalassemia in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on thalassemia in adults. The following list has been carefully curated by evaluating the ongoing phase 3 trials for thalassemia, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This compilation primarily […]

Read More
Focus
Clinical Trials
Specialties
Family Medicine • Hematology • Pediatrics • Adolescent Medicine • Pediatric Hematology/Oncology
Guidelines + Trials Rundown Ulcerative Colitis

Ulcerative Colitis in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on ulcerative colitis in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for moderately to severe ulcerative colitis, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject […]

Read More
Focus
Clinical Trials
Specialties
Family Medicine • Gastroenterology

CDC’s HIV Screening Guideline is Now Open for Public Comment

Published on

The US Centers for Disease Control and Prevention (CDC) has released the latest draft of the Recommendations for HIV Screening in Clinical Settings for public comment. This guideline aims to aid healthcare providers in diagnosing and connecting patients with undiagnosed HIV to clinical care, reestablishing individuals with previously diagnosed HIV in care, detecting HIV infection […]

Read More
Focus
Guidelines
Specialties
Family Medicine • Infectious Diseases • Infectious Disease • Internal Medicine - General • Obstetrics and Gynecology • Adolescent Medicine • Pediatric Infectious Diseases • Preventive Medicine • Public Health and General Preventive Medicine
Guidelines + Trials Rundown Crohn’s Disease

Crohn’s Disease in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on Crohn’s disease in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for Crohn’s disease, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This […]

Read More
Focus
Clinical Trials
Specialties
Gastroenterology
Guideline Timeline - Influenza Vaccine Recommendations

Influenza Vaccine Recommendations – Guidelines Timeline (National Influenza Vaccination Week)

Published on

National Influenza Vaccination Week (NIVW) is a national awareness week dedicated to emphasizing the significance of influenza vaccination. Taking place from December 2-6, 2024, National Influenza Vaccination Week 2024 serves as a timely reminder for individuals aged 6 months and older that there is still an opportunity to receive a flu vaccine this season. Given […]

Read More
Focus
Guidelines
Specialties
Family Medicine • Infectious Diseases • Infectious Disease • Internal Medicine - General • Adolescent Medicine • Pediatric Infectious Diseases • Public Health and General Preventive Medicine
Guidelines Spotlight HIVAIDS

Human Immunodeficiency Virus (HIV) Guidelines Spotlight – (World AIDS Day)

Published on

World AIDS Day is observed annually on December 1st, providing a global platform for individuals to come together in solidarity with those affected by HIV and to honor those who have succumbed to AIDS-related illnesses. Each year, World AIDS Day centers around a specific theme, with this year’s focus being on “Taking the Rights Path.” […]

Read More
Focus
Guidelines
Specialties
Family Medicine • Infectious Diseases • Infectious Disease • Adolescent Medicine • Pediatric Infectious Diseases • Public Health and General Preventive Medicine

Bictegravir, Emtricitabine, and Tenofovir Alafenamide (Biktarvy/Gilead ) – Guidelines+ Monographs

Published on

In recognition of World AIDS Day 2024, our latest edition of the Guidelines+ Monographs Series will delve into the medication bictegravir, emtricitabine, and tenofovir alafenamide, marketed under the brand name Biktarvy®  by Gilead Sciences, Inc. Biktarvy is a three-drug combination of bictegravir (BIC), a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), […]

Read More
Focus
Medications
Specialties
Family Medicine • Infectious Diseases • Infectious Disease • Internal Medicine - General • Pediatric Infectious Diseases • Public Health and General Preventive Medicine
« Back to InSights Hub